Literature DB >> 28501250

Hereditary Colorectal Cancer Syndromes.

Katerina Wells1, Paul E Wise2.   

Abstract

Awareness of hereditary colorectal cancer syndromes is important to facilitate their identification because affected patients are at increased risk for early onset, synchronous, and metachronous colorectal malignancies, and certain extracolonic malignancies depending on the syndrome. Identification of an affected individual allows for screening and early interventions for patients and their at-risk kindred. Genetic counseling and testing is important to the care of these patients. As knowledge of the genetic basis of these syndromes grows, unique genotype-phenotype profiles allow clinicians to tailor surveillance and treatment strategies based on individual risk.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Familial adenomatous polyposis; Hereditary nonpolyposis colorectal cancer; Inherited colon cancer; Lynch syndrome; MUTYH-associated polyposis; Serrated polyposis syndrome

Mesh:

Substances:

Year:  2017        PMID: 28501250     DOI: 10.1016/j.suc.2017.01.009

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  16 in total

1.  Therapy-associated myelodysplastic syndrome with monosomy 7 arising in a Muir-Torre Syndrome patient carrying SETBP1 mutation.

Authors:  David Ullman; Erin Baumgartner; Nicholas Wnukowski; Gabe Koenig; Fady M Mikhail; Peter Pavlidakey; Deniz Peker
Journal:  Mol Clin Oncol       Date:  2017-12-08

2.  Childhood socioeconomic status, healthy lifestyle, and colon cancer risk in a cohort of U.S. women.

Authors:  Anne-Josée Guimond; Emily S Zevon; Reginald D Tucker-Seeley; Edward L Giovannucci; Claudia Trudel-Fitzgerald; Laura D Kubzansky
Journal:  Prev Med       Date:  2022-05-26       Impact factor: 4.637

3.  Can Automated Alerts in the Electronic Health Record Encourage Referrals for Genetic Counseling and Testing Among Patients at High Risk for Hereditary Cancer Syndromes?

Authors:  Kristin K Zorn; Melinda E Simonson; Jennifer L Faulkner; Cyndee L Carr; Joshua Acuna; Tiffany L Hall; John F Jenkins; Karen L Drummond; Geoffrey M Curran
Journal:  JCO Oncol Pract       Date:  2022-03-22

4.  Genetic Characterization of Hereditary Cancer Syndromes Based on Targeted Next-Generation Sequencing.

Authors:  Pelin Ercoskun; Cigdem Yuce Kahraman; Guller Ozkan; Abdulgani Tatar
Journal:  Mol Syndromol       Date:  2021-11-04

5.  Rectal cancer in the young: analysis of contributing factors and surgical outcomes.

Authors:  Odinaka Mogor; Agnes Ewongwo; Ogaga Ojameruaye; Viraj Pandit; Pamela Omesiete; Carolina Martinez; Paul Hsu; Aaron Scott; Emad Elquza; Valentine Nfonsam
Journal:  J Gastrointest Oncol       Date:  2019-10

Review 6.  Genomic landscape of colorectal carcinogenesis.

Authors:  Jin Cheon Kim; Walter F Bodmer
Journal:  J Cancer Res Clin Oncol       Date:  2022-01-20       Impact factor: 4.553

7.  Postradiation Histiocytic Sarcoma in the Setting of Muir-Torre Syndrome.

Authors:  Erin Baumgartner; David Ullman; Jeffrey Adam Jones; Danielle Fasciano; Daniel S Atherton; Peter Pavlidakey; Deniz Peker
Journal:  Case Rep Pathol       Date:  2018-04-24

8.  Evidence of response to pembrolizumab in a patient with Lynch syndrome-related metastatic colon cancer.

Authors:  Pamela Salman; Sergio Panay; René Fernández; Mauricio Mahave; Cristian Soza-Ried
Journal:  Onco Targets Ther       Date:  2018-10-23       Impact factor: 4.147

9.  Clinical characteristics of patients in their forties who underwent surgical resection for colorectal cancer in Korea.

Authors:  Chang Sin Lee; Se-Jin Baek; Jung-Myun Kwak; Jin Kim; Seon-Hahn Kim
Journal:  World J Gastroenterol       Date:  2021-07-07       Impact factor: 5.742

10.  Colon cancer-induced interleukin-35 inhibits beta-catenin-mediated pro-oncogenic activity.

Authors:  Yueqiang Jiang; Yanling Ma; RuiChao Li; JianHai Sun
Journal:  Oncotarget       Date:  2017-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.